Author

Andrea Cubitt

Observed name: A Cubitt

Institution: aTyr Pharma (United States)

Observed institution: aTyr Pharma (United States)

ORCID: 0009-0002-7452-1135

Observed ORCID: 0009-0002-7452-1135

OpenAlex ID: A5048191125

Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer

2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49

Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses

2019 · Ryan A. Adams, Cátia Fernandes-Cerqueira, et al. · Cellular and Molecular Immunology · 44

Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease

2024 · Rajeev Dhupar, Amy A. Powers, et al. · Journal of Clinical Medicine · 11

Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples

2023 · Sarah Förster, Yeeting E. Chong, et al. · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 7

Abstract 3834: Antibodies targeting Resokine, a soluble immune modulator, inhibit tumor growth in syngeneic mouse models

2018 · Kathy Ogilvie, Cherie Ng, et al. · Cancer Research · 2

A novel neuropilin-2 (NRP2) antibody for immunohistochemical staining of patient tissue samples

2022 · Y Chong, S Förster, et al. · European Respiratory Journal · 1

Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase

2018 · Elisabeth C Mertsching, Jeanette Ampudia, et al. · The Journal of Immunology · 1

Abstract 2728: Circulating levels of Resokine, a soluble modulator of the immune system, are upregulated in both experimental cancer models and in patients across multiple tumor types

2018 · Ryan Adams, Elisabeth Mertsching, et al. · Cancer Research

Identification of novel liquid biopsy biomarker for monitoring the immune set point in both solid tumor and hematological malignancy patients.

2018 · David John King, Ryan Adams, et al. · Journal of Clinical Oncology

Process optimization, manufacturing changes from early to late phase development, and comparability of Resolaris

2018 · Ying Buechler, Darin Lee, et al.

Works count: 10

Citation count: 115

H-index: 4

I10-index: 3